Rivastigmine hydrogen tartrate polymorphs: Solid-state characterisation of transition and polymorphic conversion via milling
Authors:
- Maria Inês AmaroMAMaria Inês Amaro
- Alice SimonASAlice Simon
- Lúcio Mendes CabralLCLúcio Mendes Cabral
- Valéria Pereira de SousaVSValéria Pereira de Sousa
- Anne Marie HealyAHAnne Marie Healy
Open Access
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Solid State Sciences
- Vol. 49, 29-36
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation Ireland (12/RC/2275)
- FAPERJ
- CAPES (PDSE 3372/13-8)
This publication has 32 references indexed in Scilit:
- Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's diseaseInternational Journal of Nanomedicine, 2013
- Preparation, melting, glass relaxation and nonisothermal crystallization kinetics of a novel dendritic nylon-11Thermochimica Acta, 2011
- New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulationsDrug Development and Industrial Pharmacy, 2011
- Drug mechanochemical activationJournal of Pharmaceutical Sciences, 2009
- Pharmaceutical co-crystals–an opportunity for drug product enhancementExpert Opinion on Drug Delivery, 2009
- Solid State Amorphization of PharmaceuticalsMolecular Pharmaceutics, 2008
- A Nanoparticulate Drug‐Delivery System for Rivastigmine: Physico‐Chemical and in vitro Biological CharacterizationMacromolecular Bioscience, 2008
- Pharmaceutical Co-CrystalsJournal of Pharmaceutical Sciences, 2006
- Characteristics and Significance of the Amorphous State in Pharmaceutical SystemsJournal of Pharmaceutical Sciences, 1997
- Thermal analysis and calorimetric methods in the characterisation of polymorphs and solvatesThermochimica Acta, 1995